Loading...
Loading...

by Viilbery Healthcare Pvt Ltd· 10S
SKU: 935911
You save ₹20 on this order
Inclusive of all taxes
RELNOPA 75 SR TABLET is used for the management of neuropathic pain. It is a
combination of Pregabalin and Methylcobalamin which belongs to the group of
medicines called Anticonvulsants and Vitamin-B complex respectively. It consists
of Methylcobalamin and Pregabalin where Methylcobalamin acts by rejuvenating the
damaged neurons by improving the production of myelin and pregabalin acts by
interfering with various pain signals travelling through the damaged nerves and
the brain, thus leading to a significant pain relief in various neuropathic pain
states.
Do not stop taking RELNOPA 75 SR TABLET without consulting your doctor as it
could precipitate withdrawal symptoms such as headache, insomnia, nausea, pain,
diarrhea, flu syndrome, anxiety, nervousness, depression, convulsion, excessive
sweating, dizziness and physical dependence. RELNOPA 75 SR TABLET has high
potential to cause addiction and therefore caution should be exercised among
patients who already has a history of substance abuse.
RELNOPA 75 SR TABLET is not recommended for use in pregnant or breastfeeding
women unless advised by the doctor and in male patients who plan to father a
child. The most common side effects are dizziness, sleepiness, headache, dry
mouth, mood changes, fluid retention and weight gain. Consult your doctor if any
of the side effects worsen.
RELNOPA 75 SR TABLET effectively alleviates the symptoms of various types of
neuropathic pain, where Methylcobalamin acts by rejuvenating the damaged neurons
by improving the production of myelin and Pregabalin acts by interfering with
various pain signals travelling through the damaged nerves and the brain, thus
leading to a significant pain relief in various neuropathic pain states.
Stop taking RELNOPA 75 SR TABLET and contact your doctor immediately if you
experience any of the following side effects:
!### Pregnancy
Consult your doctorThere is no proper information on the use of RELNOPA 75 SR TABLET during
pregnancy and therefore should be used only if the benefit to the mother clearly
outweighs the potential risk to the fetus.
!### Breastfeeding
Monitoring requiredRELNOPA 75 SR TABLET is not recommended for use in breastfeeding women unless it
is considered clearly necessary.
!### Driving and Using Machines
Use with CautionDo not drive or operate any heavy tools or machines if you experience dizziness
or sleepiness after taking this medicine.
!### Alcohol
Consult your doctorAvoid consum
impairment of motor skills and sedating effects of alcohol.
!### Kidney
Use with CautionRELNOPA 75 SR TABLET should be taken with caution in patients with impaired
kidney function.
!### Liver
Use with CautionRELNOPA 75 SR TABLET should be taken with caution in patients with liver
disease.
!### Allergy
ContraindicatedDo not take RELNOPA 75 SR TABLET if you are allergic to Pregabalin,
Methylcobalamin or any other ingredients of this medicine.
!### Heart Disease
Use with CautionRELNOPA 75 SR TABLET should be taken with caution in patients with heart disease
such as congestive heart failure.
!### Use In Pediatrics
ContraindicatedRELNOPA 75 SR TABLET is not recommended for use in children and adolescents
(aged below 18 years) due to lack of safety data.
!### Use In Geriatrics
Use with CautionRELNOPA 75 SR TABLET should be used with caution in elderly patients (aged 65
years and above), especially in patients with decreased renal function. Proper
dose adjustments and careful monitoring of kidney function are required in such
patients.
RELNOPA 75 SR TABLET is not recommended for use if you:
Before taking this medicine, inform your physician if you:
A. Drug-Drug interactions:
Before taking the medicine, inform your doctor if you are taking any of the
following medicines:
Overdosage:
If you or anyone else accidentally takes too much of RELNOPA 75 SR TABLET,
contact your doctor immediately or go to a hospital straight away. Overdosage
symptoms such as sleepiness, confusion, agitation, restlessness or seizures.
| Drug | : | Pregabalin, Methylcobalamin |
| Pharmacological Category | : | Anticonvulsants, Vitamin B complex |
| Therapeutic Indication | : | Neuropathic pain |
| Dosage Forms | : | Tablet, Capsule, Soft gels, Syrup |
A: Fertility studies in men have shown that there were no effects on sperm
motility. However, RELNOPA 75 SR TABLET can be associated with an increased risk
of male-mediated teratogenicity (abnormalities in fetus). Men being managed with
this medicine who plan to father a child should be informed about the potential
risk of male-mediated teratogenicity. There are not enough clinical data on the
effects of this medicine on female fertility.
A: Yes. It may cause weight gain in some individuals mainly due to the formation
of peripheral edema (fluid retention). Inform your doctor if you have diabetes
prior to management with [as a precaution.
A: Yes, RELNOPA 75 SR TABLET may cause decrease in sex drive (libido) in some
individuals, although not everybody gets them.
A: Yes, RELNOPA 75 SR TABLET has high potential to create substance abuse or
dependence and therefore caution should be exercised among patients who already
has a history of substance abuse.
A: No. Do not stop taking RELNOPA 75 SR TABLET without consulting your doctor as
it could precipitate withdrawal symptoms such as headache, lack of sleep,
nausea, pain, diarrhea, flu syndrome, anxiety, nervousness, depression,
convulsion, hyperhidrosis and dizziness and dependence. If your condition
improves, contact your doctor so that he might reduce the dose appropriately
before discontinuation of the therapy with the medicine.
RELNOPA 75 SR TABLET is used for the management of neuropathic pain. It is a
combination of Pregabalin and Methylcobalamin which belongs to the group of
medicines called Anticonvulsants and Vitamin-B complex respectively. It consists
of Methylcobalamin and Pregabalin where Methylcobalamin acts by rejuvenating the
damaged neurons by improving the production of myelin and pregabalin acts by
interfering with various pain signals travelling through the damaged nerves and
the brain, thus leading to a significant pain relief in various neuropathic pain
states.
Do not stop taking RELNOPA 75 SR TABLET without consulting your doctor as it
could precipitate withdrawal symptoms such as headache, insomnia, nausea, pain,
diarrhea, flu syndrome, anxiety, nervousness, depression, convulsion, excessive
sweating, dizziness and physical dependence. RELNOPA 75 SR TABLET has high
potential to cause addiction and therefore caution should be exercised among
patients who already has a history of substance abuse.
RELNOPA 75 SR TABLET is not recommended for use in pregnant or breastfeeding
women unless advised by the doctor and in male patients who plan to father a
child. The most common side effects are dizziness, sleepiness, headache, dry
mouth, mood changes, fluid retention and weight gain. Consult your doctor if any
of the side effects worsen.
RELNOPA 75 SR TABLET effectively alleviates the symptoms of various types of
neuropathic pain, where Methylcobalamin acts by rejuvenating the damaged neurons
by improving the production of myelin and Pregabalin acts by interfering with
various pain signals travelling through the damaged nerves and the brain, thus
leading to a significant pain relief in various neuropathic pain states.
Stop taking RELNOPA 75 SR TABLET and contact your doctor immediately if you
experience any of the following side effects:
!### Pregnancy
Consult your doctorThere is no proper information on the use of RELNOPA 75 SR TABLET during
pregnancy and therefore should be used only if the benefit to the mother clearly
outweighs the potential risk to the fetus.
!### Breastfeeding
Monitoring requiredRELNOPA 75 SR TABLET is not recommended for use in breastfeeding women unless it
is considered clearly necessary.
!### Driving and Using Machines
Use with CautionDo not drive or operate any heavy tools or machines if you experience dizziness
or sleepiness after taking this medicine.
!### Alcohol
Consult your doctorAvoid consum
impairment of motor skills and sedating effects of alcohol.
!### Kidney
Use with CautionRELNOPA 75 SR TABLET should be taken with caution in patients with impaired
kidney function.
!### Liver
Use with CautionRELNOPA 75 SR TABLET should be taken with caution in patients with liver
disease.
!### Allergy
ContraindicatedDo not take RELNOPA 75 SR TABLET if you are allergic to Pregabalin,
Methylcobalamin or any other ingredients of this medicine.
!### Heart Disease
Use with CautionRELNOPA 75 SR TABLET should be taken with caution in patients with heart disease
such as congestive heart failure.
!### Use In Pediatrics
ContraindicatedRELNOPA 75 SR TABLET is not recommended for use in children and adolescents
(aged below 18 years) due to lack of safety data.
!### Use In Geriatrics
Use with CautionRELNOPA 75 SR TABLET should be used with caution in elderly patients (aged 65
years and above), especially in patients with decreased renal function. Proper
dose adjustments and careful monitoring of kidney function are required in such
patients.
RELNOPA 75 SR TABLET is not recommended for use if you:
Before taking this medicine, inform your physician if you:
A. Drug-Drug interactions:
Before taking the medicine, inform your doctor if you are taking any of the
following medicines:
Overdosage:
If you or anyone else accidentally takes too much of RELNOPA 75 SR TABLET,
contact your doctor immediately or go to a hospital straight away. Overdosage
symptoms such as sleepiness, confusion, agitation, restlessness or seizures.
| Drug | : | Pregabalin, Methylcobalamin |
| Pharmacological Category | : | Anticonvulsants, Vitamin B complex |
| Therapeutic Indication | : | Neuropathic pain |
| Dosage Forms | : | Tablet, Capsule, Soft gels, Syrup |
A: Fertility studies in men have shown that there were no effects on sperm
motility. However, RELNOPA 75 SR TABLET can be associated with an increased risk
of male-mediated teratogenicity (abnormalities in fetus). Men being managed with
this medicine who plan to father a child should be informed about the potential
risk of male-mediated teratogenicity. There are not enough clinical data on the
effects of this medicine on female fertility.
A: Yes. It may cause weight gain in some individuals mainly due to the formation
of peripheral edema (fluid retention). Inform your doctor if you have diabetes
prior to management with [as a precaution.
A: Yes, RELNOPA 75 SR TABLET may cause decrease in sex drive (libido) in some
individuals, although not everybody gets them.
A: Yes, RELNOPA 75 SR TABLET has high potential to create substance abuse or
dependence and therefore caution should be exercised among patients who already
has a history of substance abuse.
A: No. Do not stop taking RELNOPA 75 SR TABLET without consulting your doctor as
it could precipitate withdrawal symptoms such as headache, lack of sleep,
nausea, pain, diarrhea, flu syndrome, anxiety, nervousness, depression,
convulsion, hyperhidrosis and dizziness and dependence. If your condition
improves, contact your doctor so that he might reduce the dose appropriately
before discontinuation of the therapy with the medicine.